0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Vaccines Market Research Report 2020
Published Date: March 2020
|
Report Code: QYRE-Auto-32A1914
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Influenza Vaccines Market Research Report 2020

Global Influenza Vaccines Market Research Report 2020

Code: QYRE-Auto-32A1914
Report
March 2020
Pages:123
QYResearch
Description
Table of Content
Tables & Figures
The global Influenza Vaccines market is valued at US$ 3168 million in 2020 is expected to reach US$ 4390.9 million by the end of 2026, growing at a CAGR of 4.7% during 2021-2026.
This report focuses on Influenza Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Influenza Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Influenza Vaccines market is segmented into
    Trivalent Flu Vaccines
    Quadrivalent Flu Vaccines
Segment by Application
    Adults
    Pediatrics
 Global Influenza Vaccines Market: Regional Analysis
The Influenza Vaccines market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Influenza Vaccines market report are:
North America
    U.S.
    Canada
Europe
    Germany
    France
    U.K.
    Italy
    Russia
Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
Latin America
    Mexico
    Brazil
    Argentina
Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E
Global Influenza Vaccines Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Influenza Vaccines market include:
    AstraZeneca
    CSL
    GlaxoSmithKline
    Sanofi
    Altimmune
    BionVax
    FluGen
    FOLIA BIOTECH
    Genentech
    Green Cross
    Medicago
    Moderna Therapeutics
    Novavax
    Shijiazhuang Yiling Pharmaceutical
    SK Chemicals
    UNM Pharma
    Vaccitech
    Vaxart
    Vaxine Pty
    Visterra
Table of Contents
1 Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Influenza Vaccines
1.2 Influenza Vaccines Segment by Type
1.2.1 Global Influenza Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Trivalent Flu Vaccines
1.2.3 Quadrivalent Flu Vaccines
1.3 Influenza Vaccines Segment by Application
1.3.1 Influenza Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Adults
1.3.3 Pediatrics
1.4 Global Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Influenza Vaccines Revenue 2015-2026
1.4.2 Global Influenza Vaccines Sales 2015-2026
1.4.3 Influenza Vaccines Market Size by Region: 2020 Versus 2026
2 Global Influenza Vaccines Market Competition by Manufacturers
2.1 Global Influenza Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Influenza Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Influenza Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Influenza Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Influenza Vaccines Players (Opinion Leaders)
3 Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Influenza Vaccines Market Facts & Figures by Country
3.3.1 North America Influenza Vaccines Sales by Country
3.3.2 North America Influenza Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Influenza Vaccines Market Facts & Figures by Country
3.4.1 Europe Influenza Vaccines Sales by Country
3.4.2 Europe Influenza Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Influenza Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Influenza Vaccines Sales by Region
3.5.2 Asia Pacific Influenza Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Influenza Vaccines Market Facts & Figures by Country
3.6.1 Latin America Influenza Vaccines Sales by Country
3.6.2 Latin America Influenza Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Influenza Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Influenza Vaccines Sales by Country
3.7.2 Middle East and Africa Influenza Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Influenza Vaccines Historic Market Analysis by Type
4.1 Global Influenza Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Influenza Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Influenza Vaccines Price Market Share by Type (2015-2020)
4.4 Global Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Influenza Vaccines Historic Market Analysis by Application
5.1 Global Influenza Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Influenza Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Influenza Vaccines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Influenza Vaccines Business
6.1 AstraZeneca
6.1.1 Corporation Information
6.1.2 AstraZeneca Description, Business Overview and Total Revenue
6.1.3 AstraZeneca Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AstraZeneca Products Offered
6.1.5 AstraZeneca Recent Development
6.2 CSL
6.2.1 CSL Influenza Vaccines Production Sites and Area Served
6.2.2 CSL Description, Business Overview and Total Revenue
6.2.3 CSL Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 CSL Products Offered
6.2.5 CSL Recent Development
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Influenza Vaccines Production Sites and Area Served
6.3.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.3.3 GlaxoSmithKline Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GlaxoSmithKline Products Offered
6.3.5 GlaxoSmithKline Recent Development
6.4 Sanofi
6.4.1 Sanofi Influenza Vaccines Production Sites and Area Served
6.4.2 Sanofi Description, Business Overview and Total Revenue
6.4.3 Sanofi Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.4.5 Sanofi Recent Development
6.5 Altimmune
6.5.1 Altimmune Influenza Vaccines Production Sites and Area Served
6.5.2 Altimmune Description, Business Overview and Total Revenue
6.5.3 Altimmune Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Altimmune Products Offered
6.5.5 Altimmune Recent Development
6.6 BionVax
6.6.1 BionVax Influenza Vaccines Production Sites and Area Served
6.6.2 BionVax Description, Business Overview and Total Revenue
6.6.3 BionVax Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BionVax Products Offered
6.6.5 BionVax Recent Development
6.7 FluGen
6.6.1 FluGen Influenza Vaccines Production Sites and Area Served
6.6.2 FluGen Description, Business Overview and Total Revenue
6.6.3 FluGen Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 FluGen Products Offered
6.7.5 FluGen Recent Development
6.8 FOLIA BIOTECH
6.8.1 FOLIA BIOTECH Influenza Vaccines Production Sites and Area Served
6.8.2 FOLIA BIOTECH Description, Business Overview and Total Revenue
6.8.3 FOLIA BIOTECH Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 FOLIA BIOTECH Products Offered
6.8.5 FOLIA BIOTECH Recent Development
6.9 Genentech
6.9.1 Genentech Influenza Vaccines Production Sites and Area Served
6.9.2 Genentech Description, Business Overview and Total Revenue
6.9.3 Genentech Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Genentech Products Offered
6.9.5 Genentech Recent Development
6.10 Green Cross
6.10.1 Green Cross Influenza Vaccines Production Sites and Area Served
6.10.2 Green Cross Description, Business Overview and Total Revenue
6.10.3 Green Cross Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Green Cross Products Offered
6.10.5 Green Cross Recent Development
6.11 Medicago
6.11.1 Medicago Influenza Vaccines Production Sites and Area Served
6.11.2 Medicago Influenza Vaccines Description, Business Overview and Total Revenue
6.11.3 Medicago Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Medicago Products Offered
6.11.5 Medicago Recent Development
6.12 Moderna Therapeutics
6.12.1 Moderna Therapeutics Influenza Vaccines Production Sites and Area Served
6.12.2 Moderna Therapeutics Influenza Vaccines Description, Business Overview and Total Revenue
6.12.3 Moderna Therapeutics Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Moderna Therapeutics Products Offered
6.12.5 Moderna Therapeutics Recent Development
6.13 Novavax
6.13.1 Novavax Influenza Vaccines Production Sites and Area Served
6.13.2 Novavax Influenza Vaccines Description, Business Overview and Total Revenue
6.13.3 Novavax Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Novavax Products Offered
6.13.5 Novavax Recent Development
6.14 Shijiazhuang Yiling Pharmaceutical
6.14.1 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Sites and Area Served
6.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Description, Business Overview and Total Revenue
6.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Shijiazhuang Yiling Pharmaceutical Products Offered
6.14.5 Shijiazhuang Yiling Pharmaceutical Recent Development
6.15 SK Chemicals
6.15.1 SK Chemicals Influenza Vaccines Production Sites and Area Served
6.15.2 SK Chemicals Influenza Vaccines Description, Business Overview and Total Revenue
6.15.3 SK Chemicals Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.15.4 SK Chemicals Products Offered
6.15.5 SK Chemicals Recent Development
6.16 UNM Pharma
6.16.1 UNM Pharma Influenza Vaccines Production Sites and Area Served
6.16.2 UNM Pharma Influenza Vaccines Description, Business Overview and Total Revenue
6.16.3 UNM Pharma Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.16.4 UNM Pharma Products Offered
6.16.5 UNM Pharma Recent Development
6.17 Vaccitech
6.17.1 Vaccitech Influenza Vaccines Production Sites and Area Served
6.17.2 Vaccitech Influenza Vaccines Description, Business Overview and Total Revenue
6.17.3 Vaccitech Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Vaccitech Products Offered
6.17.5 Vaccitech Recent Development
6.18 Vaxart
6.18.1 Vaxart Influenza Vaccines Production Sites and Area Served
6.18.2 Vaxart Influenza Vaccines Description, Business Overview and Total Revenue
6.18.3 Vaxart Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Vaxart Products Offered
6.18.5 Vaxart Recent Development
6.19 Vaxine Pty
6.19.1 Vaxine Pty Influenza Vaccines Production Sites and Area Served
6.19.2 Vaxine Pty Influenza Vaccines Description, Business Overview and Total Revenue
6.19.3 Vaxine Pty Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Vaxine Pty Products Offered
6.19.5 Vaxine Pty Recent Development
6.20 Visterra
6.20.1 Visterra Influenza Vaccines Production Sites and Area Served
6.20.2 Visterra Influenza Vaccines Description, Business Overview and Total Revenue
6.20.3 Visterra Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Visterra Products Offered
6.20.5 Visterra Recent Development
7 Influenza Vaccines Manufacturing Cost Analysis
7.1 Influenza Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Influenza Vaccines
7.4 Influenza Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Influenza Vaccines Distributors List
8.3 Influenza Vaccines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Influenza Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Influenza Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Influenza Vaccines by Type (2021-2026)
10.2 Influenza Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Influenza Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Influenza Vaccines by Application (2021-2026)
10.3 Influenza Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Influenza Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Influenza Vaccines by Region (2021-2026)
10.4 North America Influenza Vaccines Estimates and Projections (2021-2026)
10.5 Europe Influenza Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Influenza Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Influenza Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Influenza Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Influenza Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026)
    Table 2. Global Influenza Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026
    Table 3. Global Influenza Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
    Table 4. Global Key Influenza Vaccines Manufacturers Covered in This Study
    Table 5. Global Influenza Vaccines Sales (K Units) by Manufacturers (2015-2020)
    Table 6. Global Influenza Vaccines Sales Share by Manufacturers (2015-2020)
    Table 7. Global Influenza Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
    Table 8. Global Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
    Table 9. Global Market Influenza Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
    Table 10. Manufacturers Influenza Vaccines Sales Sites and Area Served
    Table 11. Manufacturers Influenza Vaccines Product Types
    Table 12. Global Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccines as of 2019)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Main Points Interviewed from Key Influenza Vaccines Players
    Table 16. Global Influenza Vaccines Sales (K Units) by Region (2015-2020)
    Table 17. Global Influenza Vaccines Sales Market Share by Region (2015-2020)
    Table 18. Global Influenza Vaccines Revenue (Million US$) by Region (2015-2020)
    Table 19. Global Influenza Vaccines Revenue Market Share by Region (2015-2020)
    Table 20. North America Influenza Vaccines Sales by Country (2015-2020) (K Units)
    Table 21. North America Influenza Vaccines Sales Market Share by Country (2015-2020)
    Table 22. North America Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
    Table 23. North America Influenza Vaccines Revenue Market Share by Country (2015-2020)
    Table 24. Europe Influenza Vaccines Sales by Country (2015-2020) (K Units)
    Table 25. Europe Influenza Vaccines Sales Market Share by Country (2015-2020)
    Table 26. Europe Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
    Table 27. Europe Influenza Vaccines Revenue Market Share by Country (2015-2020)
    Table 28. Asia Pacific Influenza Vaccines Sales by Region (2015-2020) (K Units)
    Table 29. Asia Pacific Influenza Vaccines Sales Market Share by Region (2015-2020)
    Table 30. Asia Pacific Influenza Vaccines Revenue by Region (2015-2020) (US$ Million)
    Table 31. Asia Pacific Influenza Vaccines Revenue Market Share by Region (2015-2020)
    Table 32. Latin America Influenza Vaccines Sales by Country (2015-2020) (K Units)
    Table 33. Latin America Influenza Vaccines Sales Market Share by Country (2015-2020)
    Table 34. Latin America Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
    Table 35. Latin America Influenza Vaccines Revenue Market Share by Country (2015-2020)
    Table 36. Middle East and Africa Influenza Vaccines Sales by Country (2015-2020) (K Units)
    Table 37. Middle East and Africa Influenza Vaccines Sales Market Share by Country (2015-2020)
    Table 38. Middle East and Africa Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
    Table 39. Middle East and Africa Influenza Vaccines Revenue Market Share by Country (2015-2020)
    Table 40. Global Influenza Vaccines Sales (K Units) by Type (2015-2020)
    Table 41. Global Influenza Vaccines Sales Share by Type (2015-2020)
    Table 42. Global Influenza Vaccines Revenue (Million US$) by Type (2015-2020)
    Table 43. Global Influenza Vaccines Revenue Share by Type (2015-2020)
    Table 44. Global Influenza Vaccines Price (USD/Unit) by Type (2015-2020)
    Table 45. Global Influenza Vaccines Sales (K Units) by Application (2015-2020)
    Table 46. Global Influenza Vaccines Sales Market Share by Application (2015-2020)
    Table 47. Global Influenza Vaccines Sales Growth Rate by Application (2015-2020)
    Table 48. AstraZeneca Influenza Vaccines Corporation Information
    Table 49. AstraZeneca Description and Business Overview
    Table 50. AstraZeneca Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 51. AstraZeneca Main Product
    Table 52. AstraZeneca Recent Development
    Table 53. CSL Influenza Vaccines Corporation Information
    Table 54. CSL Corporation Information
    Table 55. CSL Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 56. CSL Main Product
    Table 57. CSL Recent Development
    Table 58. GlaxoSmithKline Influenza Vaccines Corporation Information
    Table 59. GlaxoSmithKline Corporation Information
    Table 60. GlaxoSmithKline Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 61. GlaxoSmithKline Main Product
    Table 62. GlaxoSmithKline Recent Development
    Table 63. Sanofi Influenza Vaccines Corporation Information
    Table 64. Sanofi Corporation Information
    Table 65. Sanofi Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 66. Sanofi Main Product
    Table 67. Sanofi Recent Development
    Table 68. Altimmune Influenza Vaccines Corporation Information
    Table 69. Altimmune Corporation Information
    Table 70. Altimmune Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 71. Altimmune Main Product
    Table 72. Altimmune Recent Development
    Table 73. BionVax Influenza Vaccines Corporation Information
    Table 74. BionVax Corporation Information
    Table 75. BionVax Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 76. BionVax Main Product
    Table 77. BionVax Recent Development
    Table 78. FluGen Influenza Vaccines Corporation Information
    Table 79. FluGen Corporation Information
    Table 80. FluGen Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 81. FluGen Main Product
    Table 82. FluGen Recent Development
    Table 83. FOLIA BIOTECH Influenza Vaccines Corporation Information
    Table 84. FOLIA BIOTECH Corporation Information
    Table 85. FOLIA BIOTECH Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 86. FOLIA BIOTECH Main Product
    Table 87. FOLIA BIOTECH Recent Development
    Table 88. Genentech Influenza Vaccines Corporation Information
    Table 89. Genentech Corporation Information
    Table 90. Genentech Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 91. Genentech Main Product
    Table 92. Genentech Recent Development
    Table 93. Green Cross Influenza Vaccines Corporation Information
    Table 94. Green Cross Corporation Information
    Table 95. Green Cross Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 96. Green Cross Main Product
    Table 97. Green Cross Recent Development
    Table 98. Medicago Influenza Vaccines Corporation Information
    Table 99. Medicago Corporation Information
    Table 100. Medicago Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 101. Medicago Main Product
    Table 102. Medicago Recent Development
    Table 103. Moderna Therapeutics Influenza Vaccines Corporation Information
    Table 104. Moderna Therapeutics Corporation Information
    Table 105. Moderna Therapeutics Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 106. Moderna Therapeutics Main Product
    Table 107. Moderna Therapeutics Recent Development
    Table 108. Novavax Influenza Vaccines Corporation Information
    Table 109. Novavax Corporation Information
    Table 110. Novavax Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 111. Novavax Main Product
    Table 112. Novavax Recent Development
    Table 113. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Corporation Information
    Table 114. Shijiazhuang Yiling Pharmaceutical Corporation Information
    Table 115. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 116. Shijiazhuang Yiling Pharmaceutical Main Product
    Table 117. Shijiazhuang Yiling Pharmaceutical Recent Development
    Table 118. SK Chemicals Influenza Vaccines Corporation Information
    Table 119. SK Chemicals Corporation Information
    Table 120. SK Chemicals Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 121. SK Chemicals Main Product
    Table 122. SK Chemicals Recent Development
    Table 123. UNM Pharma Influenza Vaccines Corporation Information
    Table 124. UNM Pharma Corporation Information
    Table 125. UNM Pharma Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 126. UNM Pharma Main Product
    Table 127. UNM Pharma Recent Development
    Table 128. Vaccitech Influenza Vaccines Corporation Information
    Table 129. Vaccitech Corporation Information
    Table 130. Vaccitech Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 131. Vaccitech Main Product
    Table 132. Vaccitech Recent Development
    Table 133. Vaxart Influenza Vaccines Corporation Information
    Table 134. Vaxart Corporation Information
    Table 135. Vaxart Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 136. Vaxart Main Product
    Table 137. Vaxart Recent Development
    Table 138. Vaxine Pty Influenza Vaccines Corporation Information
    Table 139. Vaxine Pty Corporation Information
    Table 140. Vaxine Pty Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 141. Vaxine Pty Main Product
    Table 142. Vaxine Pty Recent Development
    Table 143. Visterra Influenza Vaccines Corporation Information
    Table 144. Visterra Corporation Information
    Table 145. Visterra Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 146. Visterra Main Product
    Table 147. Visterra Recent Development
    Table 148. Sales Base and Market Concentration Rate of Raw Material
    Table 149. Key Suppliers of Raw Materials
    Table 150. Influenza Vaccines Distributors List
    Table 151. Influenza Vaccines Customers List
    Table 152. Market Key Trends
    Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 154. Key Challenges
    Table 155. Global Influenza Vaccines Sales (K Units) Forecast by Type (2021-2026)
    Table 156. Global Influenza Vaccines Sales Market Share Forecast by Type (2021-2026)
    Table 157. Global Influenza Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
    Table 158. Global Influenza Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
    Table 159. Global Influenza Vaccines Sales (K Units) Forecast by Application (2021-2026)
    Table 160. Global Influenza Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
    Table 161. Global Influenza Vaccines Sales (K Units) Forecast by Region (2021-2026)
    Table 162. Global Influenza Vaccines Sales Market Share Forecast by Region (2021-2026)
    Table 163. Global Influenza Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 164. Global Influenza Vaccines Revenue Market Share Forecast by Region (2021-2026)
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Picture of Influenza Vaccines
    Figure 2. Global Influenza Vaccines Sales Market Share by Type: 2020 VS 2026
    Figure 3. Trivalent Flu Vaccines Product Picture
    Figure 4. Quadrivalent Flu Vaccines Product Picture
    Figure 5. Global Influenza Vaccines Consumption Market Share by Application: 2020 VS 2026
    Figure 6. Adults
    Figure 7. Pediatrics
    Figure 8. Global Influenza Vaccines Market Size 2015-2026 (US$ Million)
    Figure 9. Global Influenza Vaccines Sales Capacity (K Units) (2015-2026)
    Figure 10. Global Influenza Vaccines Market Size Market Share by Region: 2020 Versus 2026
    Figure 11. Influenza Vaccines Sales Share by Manufacturers in 2020
    Figure 12. Global Influenza Vaccines Revenue Share by Manufacturers in 2019
    Figure 13. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccines Revenue in 2019
    Figure 14. Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 15. Global Influenza Vaccines Sales Market Share by Region (2015-2020)
    Figure 16. Global Influenza Vaccines Sales Market Share by Region in 2019
    Figure 17. Global Influenza Vaccines Revenue Market Share by Region (2015-2020)
    Figure 18. Global Influenza Vaccines Revenue Market Share by Region in 2019
    Figure 19. North America Influenza Vaccines Sales Market Share by Country in 2019
    Figure 20. North America Influenza Vaccines Revenue Market Share by Country in 2019
    Figure 21. U.S. Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 22. U.S. Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 23. Canada Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 24. Canada Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 25. Europe Influenza Vaccines Sales Market Share by Country in 2019
    Figure 26. Europe Influenza Vaccines Revenue Market Share by Country in 2019
    Figure 27. Germany Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 28. Germany Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 29. France Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 30. France Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 31. U.K. Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 32. U.K. Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 33. Italy Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 34. Italy Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 35. Russia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 36. Russia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 37. Asia Pacific Influenza Vaccines Sales Market Share by Region in 2019
    Figure 38. Asia Pacific Influenza Vaccines Revenue Market Share by Region in 2019
    Figure 39. China Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 40. China Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 41. Japan Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 42. Japan Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 43. South Korea Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 44. South Korea Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. India Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 46. India Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 47. Australia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 48. Australia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 49. Taiwan Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 50. Taiwan Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. Indonesia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 52. Indonesia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. Thailand Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 54. Thailand Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 55. Malaysia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 56. Malaysia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 57. Philippines Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 58. Philippines Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 59. Vietnam Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 60. Vietnam Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 61. Latin America Influenza Vaccines Sales Market Share by Country in 2019
    Figure 62. Latin America Influenza Vaccines Revenue Market Share by Country in 2019
    Figure 63. Mexico Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 64. Mexico Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. Brazil Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 66. Brazil Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 67. Argentina Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 68. Argentina Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. Middle East and Africa Influenza Vaccines Sales Market Share by Country in 2019
    Figure 70. Middle East and Africa Influenza Vaccines Revenue Market Share by Country in 2019
    Figure 71. Turkey Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 72. Turkey Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Saudi Arabia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 74. Saudi Arabia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. U.A.E Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
    Figure 76. U.A.E Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Sales Market Share of Influenza Vaccines by Type (2015-2020)
    Figure 78. Sales Market Share of Influenza Vaccines by Type in 2019
    Figure 79. Revenue Share of Influenza Vaccines by Type (2015-2020)
    Figure 80. Revenue Market Share of Influenza Vaccines by Type in 2019
    Figure 81. Global Influenza Vaccines Sales Growth by Type (2015-2020) (K Units)
    Figure 82. Global Influenza Vaccines Sales Market Share by Application (2015-2020)
    Figure 83. Global Influenza Vaccines Sales Market Share by Application in 2019
    Figure 84. Global Revenue Share of Influenza Vaccines by Application (2015-2020)
    Figure 85. Global Revenue Share of Influenza Vaccines by Application in 2020
    Figure 86. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 87. CSL Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 88. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 89. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 90. Altimmune Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 91. BionVax Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 92. FluGen Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 93. FOLIA BIOTECH Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 94. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 95. Green Cross Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 96. Medicago Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 97. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 98. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 99. Shijiazhuang Yiling Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 100. SK Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 101. UNM Pharma Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 102. Vaccitech Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 103. Vaxart Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 104. Vaxine Pty Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 105. Visterra Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 106. Price Trend of Key Raw Materials
    Figure 107. Manufacturing Cost Structure of Influenza Vaccines
    Figure 108. Manufacturing Process Analysis of Influenza Vaccines
    Figure 109. Influenza Vaccines Industrial Chain Analysis
    Figure 110. Channels of Distribution
    Figure 111. Distributors Profiles
    Figure 112. Porter's Five Forces Analysis
    Figure 113. North America Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 114. North America Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 115. Europe Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 116. Europe Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 117. Latin America Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 118. Latin America Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 119. Middle East and Africa Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 120. Middle East and Africa Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 121. Asia Pacific Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 122. Asia Pacific Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 123. Bottom-up and Top-down Approaches for This Report
    Figure 124. Data Triangulation
    Figure 125. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Infectious Enteritis Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34R5707
Thu Jul 18 00:00:00 UTC 2024

Add to Cart

Global Sterile and Antiviral Packaging Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5D8328
Fri Jul 12 00:00:00 UTC 2024

Add to Cart

Global Influenza Virus Vector Vaccine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36T5762
Mon Jul 08 00:00:00 UTC 2024

Add to Cart

Global COVID-19 DNA Vaccine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7W6043
Mon Jul 08 00:00:00 UTC 2024

Add to Cart